GlassScriptPhysician profile
Benjamin Gregory Selle
NPI 1699296756
$19,855.89
in general payments reported to CMS, 2019-2025
29 companies · $1,158 in 2025
The $1,158 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $653 · 2020: $259 · 2021: $533 · 2022: $4,261 · 2023: $9,658 · 2024: $3,333 · 2025: $1,158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,094 · Travel and Lodging: $3,071 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,440 · Honoraria: $1,000 · Education: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,093.92 |
| Travel and Lodging | $3,070.64 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,440.00 |
| Honoraria | $1,000.00 |
| Education | $544.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,595.77 | 2022-2025 | Endurant Iis, Hawkone, Turbohawk |
| Philips North America LLC | $4,029.59 | 2023-2025 | (9520) Igt Devices Undivided, (6554) Periph Vasc Undiv, (6577) Visions 014 |
| W. L. Gore & Associates, INC. | $3,074.29 | 2022-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Thoracic Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Penumbra, INC. | $2,402.69 | 2023-2025 | Indigo System, Penumbra System |
| Cook Medical LLC | $1,308.98 | 2022-2025 | Zenith Alpha, Zenith Spiral-Z, Cook |
| Silk Road Medical, INC. | $773.48 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Tela Bio, INC. | $436.56 | 2019-2021 | |
| Cardiovascular Systems INC. | $405.55 | 2020-2022 | |
| Abbott Laboratories | $398.29 | 2022 | |
| Boston Scientific Corporation | $318.76 | 2025 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Medical Device Business Services, INC. | $305.00 | 2022 | |
| Rti Surgical, INC | $303.03 | 2022 | |
| Stryker Corporation | $217.71 | 2020-2025 | Limflow System |
| Axonics, INC. | $150.00 | 2024 | Axonics |
| Integra Lifesciences Corporation | $139.48 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $131.21 | 2019 | |
| Ethicon US, LLC | $118.67 | 2022 | |
| Bolton Medical INC | $95.27 | 2023 | Treo Abdominal Stent-Graft System |
| Organogenesis INC. | $92.59 | 2024 | Puraply Am |
| Depuy Synthes Sales INC. | $91.55 | 2019 | |
| Terumo Medical Corporation | $87.22 | 2024 | Azur Cx Detachable |
| Smith+Nephew, INC. | $78.22 | 2020-2021 | |
| Intuitive Surgical, INC. | $66.37 | 2019 | |
| Endologix LLC | $57.31 | 2023 | Alto Abdominal Stent Graft System |
| Baudax Bio INC. | $51.07 | 2022 | |
| Acell, INC. | $48.64 | 2019-2020 | |
| Surmodics, INC. | $29.84 | 2023 | Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Pounce Thrombectomy |
| Allergan, INC. | $25.53 | 2020 | |
| Cvrx, INC. | $23.22 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Selle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.